EP Wealth Advisors LLC Buys 4,675 Shares of Avanos Medical, Inc. $AVNS

EP Wealth Advisors LLC grew its stake in Avanos Medical, Inc. (NYSE:AVNS) by 46.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,783 shares of the company’s stock after acquiring an additional 4,675 shares during the quarter. EP Wealth Advisors LLC’s holdings in Avanos Medical were worth $212,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of AVNS. State of Wyoming boosted its stake in Avanos Medical by 132.0% in the 4th quarter. State of Wyoming now owns 5,137 shares of the company’s stock worth $82,000 after purchasing an additional 2,923 shares in the last quarter. Heritage Family Offices LLP bought a new position in shares of Avanos Medical in the first quarter worth approximately $146,000. EntryPoint Capital LLC purchased a new stake in shares of Avanos Medical during the first quarter valued at approximately $181,000. ProShare Advisors LLC increased its position in shares of Avanos Medical by 44.4% during the fourth quarter. ProShare Advisors LLC now owns 13,693 shares of the company’s stock valued at $218,000 after acquiring an additional 4,210 shares in the last quarter. Finally, US Bancorp DE increased its position in shares of Avanos Medical by 7.7% during the first quarter. US Bancorp DE now owns 15,184 shares of the company’s stock valued at $218,000 after acquiring an additional 1,091 shares in the last quarter. 95.17% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Gary Blackford bought 40,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 13th. The stock was purchased at an average price of $10.99 per share, for a total transaction of $439,600.00. Following the completion of the transaction, the director owned 40,000 shares in the company, valued at $439,600. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. 2.64% of the stock is owned by insiders.

Analyst Ratings Changes

Several analysts have commented on the company. Wall Street Zen downgraded Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 9th. Zacks Research raised Avanos Medical to a “hold” rating in a report on Tuesday, August 12th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold”.

Avanos Medical Stock Performance

AVNS stock opened at $12.36 on Wednesday. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.64 and a quick ratio of 1.58. Avanos Medical, Inc. has a 1 year low of $9.30 and a 1 year high of $25.36. The company has a market cap of $573.53 million, a P/E ratio of -1.23 and a beta of 1.12. The stock’s fifty day moving average price is $11.64 and its 200-day moving average price is $12.65.

Avanos Medical (NYSE:AVNS) last announced its earnings results on Tuesday, August 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). Avanos Medical had a negative net margin of 66.89% and a positive return on equity of 6.16%. The business had revenue of $175.00 million for the quarter, compared to the consensus estimate of $165.50 million. During the same quarter last year, the firm posted $0.34 earnings per share. Avanos Medical has set its FY 2025 guidance at 0.750-0.950 EPS. On average, equities analysts forecast that Avanos Medical, Inc. will post 1.32 earnings per share for the current year.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.